RAB11A and juvenile Huntington disease: Reduced activity or expression levels of Rab11 have been reported in experimental models of Huntington’s disease, Parkinson’s disease and in patients with amyotrophic lateral sclerosis (Li et al., 2009a, Li et al., 2010; Breda et al., 2015; Mitra et al., 2019; Rai and Kumar Roy, 2022).